Sumita Paul

Dr. Sumita Paul, MD, MPH, MBA, is a highly accomplished cardiologist, serial-entrepreneur, and pharmaceutical drug developer with over 30 years of experience in leadership roles encompassing clinical research, clinical cardiology, medical affairs, regulatory strategy, business development, and commercialization.

She pursued her education diligently, completing her Master of Public Health (MPH) with a focus on Epidemiology at Harvard University, followed by her residency and clinical cardiology training at Massachusetts General Hospital affiliated with Harvard Medical School. Additionally, she holds US board-certification in internal medicine and cardiology. Dr. Paul furthered her expertise by obtaining a Masters in Business Administration from The Wharton School, demonstrating her commitment to a multifaceted approach to healthcare and business.

With a diverse skill set, Dr. Paul has led initiatives across various therapeutic areas including rare diseases, cardiovascular thrombosis, ischemic heart disease, heart failure, cardiovascular prevention, lipids, diabetes, neurology, and oncology. Her adeptness in managing cross-functional teams and steering high priority early and late-stage development projects has established her as a seasoned professional in the industry. She possesses a vast network and robust working relationships within industry, academia, and business arenas.

Dr. Paul has held key roles in prestigious organizations, serving as the Global Head of Clinical Development for Rare Diseases and Program Lead for PB1046 & PB6440 at PhaseBio Pharmaceuticals, Inc. Previously, she contributed her expertise as the Vice President of Research and Development at Summit Therapeutics, Head of Clinical Research & Development at American Regent, Inc., and Senior Medical Director at Amarin Corporation. Her career highlights also include roles such as Lovenox Program Lead on the Launch Team within Medical Affairs at Rhone-Poulenc Rorer, Principal Investigator for the Lovenox Phase III Trial at Brigham & Women's Hospital affiliated with Harvard University, and positions involving clinical practice and editorial responsibilities.

Throughout her professional journey, Dr. Sumita Paul has made significant contributions to the fields of cardiology, drug development, and healthcare management, reflecting her commitment to advancing medical science and patient care.